1-Oleoyl-2-docosahexaenoyl phosphatidylcholine increased paradoxical sleep in F344 rats.
Level 5 - mechanism / opinion, no new human data
Animal laboratory experiment without human clinical data
PubMed 8233070 · doi:10.1016/0304-3940(93)90604-j
What was done
Male F344 rats received intracerebroventricular administration of 1-oleoyl-2-docosahexaenoyl-sn-glycero-3-phosphorylcholine (O-DH-PC, 10 micrograms/rat) or glycerophosphorylcholine (GPC) to evaluate their effects on sleep architecture over the subsequent 24 hours.
What was found
Administration of O-DH-PC significantly increased paradoxical sleep time and total sleep time over the following 24 hours, whereas GPC administration did not. The abstract provides no numerical measurements, baseline values, or exact test statistics.
Why it matters
The findings suggest that specific phosphatidylcholines containing oleoyl and docosahexaenoyl fatty acid chains can modulate central sleep regulation in rats, likely mediated by the fatty acid components rather than the choline residue.
Limits
This study was conducted exclusively in a rodent model using invasive intracerebroventricular delivery, limiting translation to human physiology or standard oral administration. The abstract lacks sample size information, quantitative duration data, and exact statistical effect sizes.
Cited by
- contradicts Alpha-GPC improves REM sleep duration.